Rocket Pharmaceuticals, Inc. Stock price
Equities
RCKT
US77313F1066
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.94 USD | -1.14% | -2.78% | -10.11% |
Mar. 26 | Rocket Pharmaceuticals Appoints Aaron Ondrey as CFO | MT |
Mar. 26 | Rocket Pharmaceuticals, Inc. Announces Appointment of Aaron Ondrey as Chief Financial Officer | CI |
Financials (USD)
Sales 2024 * | 23.11M | Sales 2025 * | 192M | Capitalization | 2.44B |
---|---|---|---|---|---|
Net income 2024 * | -262M | Net income 2025 * | -217M | EV / Sales 2024 * | 98.1 x |
Net cash position 2024 * | 172M | Net cash position 2025 * | 39.19M | EV / Sales 2025 * | 12.5 x |
P/E ratio 2024 * |
-10.1
x | P/E ratio 2025 * |
-14.3
x | Employees | 268 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.49% |
Latest transcript on Rocket Pharmaceuticals, Inc.
1 day | -1.14% | ||
1 week | -2.78% | ||
Current month | -8.05% | ||
1 month | -7.20% | ||
3 months | -12.82% | ||
6 months | +29.89% | ||
Current year | -10.11% |
Managers | Title | Age | Since |
---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 18-01-03 |
Kinnari Patel
PSD | President | 46 | 18-01-03 |
Chief Tech/Sci/R&D Officer | 60 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 18-01-03 | |
Carsten Boess
BRD | Director/Board Member | 57 | 15-12-31 |
David Southwell
BRD | Director/Board Member | 63 | 14-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.15% | 2 M€ | -.--% | ||
0.13% | 0 M€ | 0.00% | - | |
0.09% | 0 M€ | 0.00% | - | |
0.06% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 26.94 | -1.14% | 498,831 |
24-03-27 | 27.25 | +2.60% | 489,629 |
24-03-26 | 26.56 | -1.26% | 499,223 |
24-03-25 | 26.9 | -1.14% | 310,921 |
24-03-22 | 27.21 | -1.80% | 503,544 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.11% | 2.47B | |
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |